NCT05595434

Brief Summary

Reality-monitoring is a crucial cognitive process in daily life to remember the source of an information. Deficits of reality-monitoring have been shown into the continuum of schizophrenia, suggesting a preexisting alteration in population at-risk for psychosis that will be exacerbated during psychotic transition. It is admitted that stress plays a crucial role in the psychotic transition and can alter cognitive performances. However, less is known about the effects of stress on reality-monitoring, even though this process appears to be central in psychotic disorders. The aim of this project is to investigate the effect of stress on reality-monitoring, both on behavioral and neurophysiological aspects

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 27, 2022

Completed
1.5 years until next milestone

Study Start

First participant enrolled

April 25, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2025

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 16, 2025

Completed
Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

1.5 years

First QC Date

October 13, 2022

Last Update Submit

July 23, 2025

Conditions

Keywords

reality-monitoringstress

Outcome Measures

Primary Outcomes (1)

  • Reality-monitoring performances

    scores obtained at the reality-monitoring task (accuracy, range 0-100%)

    within 1 hour after the stress procedure

Secondary Outcomes (13)

  • electroencephalogram (EEG) activity

    1time within 1 hour after the stress procedure

  • Working memory

    1 time within 1 hour after the stress procedure

  • Basic auditory performances

    1 time within 1 hour after the stress procedure

  • Salivary cortisol

    throughout and within 1 hour after the stress procedure

  • Blood pressure

    throughout and within 1 hour after the stress procedure

  • +8 more secondary outcomes

Study Arms (2)

active stress group

EXPERIMENTAL

20 healthy subjects will be subject to the active condition of a standardized stress protocol

Procedure: Acute Maastricht Stress Test (MAST), active condition.

placebo stress group

PLACEBO COMPARATOR

20 healthy subjects will be subject to the placebo condition of a standardized stress protocol.

Procedure: Acute Maastricht Stress Test (MAST), placebo condition

Interventions

The MAST is a standardized stress protocol combining a 5 min preparation phase and 10 min acute stress phase. The last phase is composed by an alternation of physical and psychosocial stressors. In the active condition, participants have to switch between immersion of the hand into cold water and complex mental arithmetic operations.

active stress group

The MAST is a standardized stress protocol combining a 5 min preparation phase and 10 min acute stress phase. The last phase is composed by an alternation of physical and psychosocial stressors. In the placebo condition, participants have to switch between immersion of the hand into tempered water and simple mental arithmetic counts.

placebo stress group

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Right-handed Men and Women aged between 18 and 30
  • Having given their written informed consent
  • For women: oral contraceptive use
  • French speakers and readers

You may not qualify if:

  • Do not consent to be included in the study
  • Smokers
  • Night workers
  • Having visual or hearing impairments that could prevent the successful completion of tasks involving reading or listening to sounds
  • Taking drug treatment (except oral contraceptive)
  • Having a somatic pathology in particular neurological, endocrinal or blood circulation diseases (e.g., Raynaud's disease)
  • Having personal or first-degree relatives' history of diagnosed psychiatric disorders (according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders - DSM5)
  • Having psychotic prodomes measured by a score above 6 in the "prodomal questionnaire' - PQ-16 (Ising et al., 2012)
  • Having developed musical abilities (that is, regularly practicing a musical instrument)
  • Being pregnant or nursing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier le Vinatier

Bron, 69678, France

RECRUITING

Study Officials

  • Mondino Marine, PhD

    hospital le vinatier

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not be informed about the nature (active or placebo) of the stress test they will perform.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Randomized, controlled, single-blind study including 40 healthy subjects who will be randomly divided into 2 groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 13, 2022

First Posted

October 27, 2022

Study Start

April 25, 2024

Primary Completion

October 25, 2025

Study Completion

November 16, 2025

Last Updated

July 24, 2025

Record last verified: 2025-07

Locations